1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antacid Market - By Dosage Form
1.3.2 Antacid Market - By Drug Class
1.3.3 Antacid Market - By Distribution Channel
1.3.4 Middle East and Africa Antacid Market - By Country

2. Middle East and Africa Antacid Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East and Africa Antacid Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antacid Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion

5. Middle East and Africa Antacid Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
5.1.2 Increase in Prevalence of Obesity
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Research Activities and Research Funds on GI Disorders
5.4 Future Trends
5.4.1 Rising Development of the Pharmaceutical Industry
5.5 Impact Analysis

6. Antacid Market - Middle East and Africa Analysis
6.1 Middle East and Africa Antacid Market Revenue Forecasts and Analysis

7. Middle East and Africa Antacid Market Analysis and Forecasts To 2027 - By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

8. Middle East and Africa Antacid Market Analysis and Forecasts to 2027- By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.4 H? Antagonist
8.4.1 Overview
8.4.2 H? Antagonist: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

9. Middle East and Africa Antacid Market Analysis and Forecasts to 2027- By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

10. Antacid Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 Middle East & Africa: Antacid Market
10.1.1 Overview
10.1.2 Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
10.1.3 Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Saudi Arabia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.1.3.3 Saudi Arabia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.3.3.1 Saudi Arabia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.1.3.4 Saudi Arabia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.4 UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.4.1 UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.4.2 UAE: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.1.4.3 UAE: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.4.3.1 UAE: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.1.4.4 UAE: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.5 South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.5.1 South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.5.2 South Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.1.5.3 South Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.5.3.1 South Africa: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.1.5.4 South Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.6 Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Rest of Middle East and Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.1.6.3 Rest of Middle East and Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.6.3.1 Rest of Middle East and Africa: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Rest of Middle East and Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Middle East and Africa Antacid Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview

13. COMPANY PROFILES
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms

Figure 1. Antacid Market Segmentation
Figure 2. Middle East and Africa Antacid Market Overview
Figure 3. Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market
Figure 4. Tablet Segment Held Largest Share of Dosage Form in Antacid Market
Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Antacid Market - Middle East and Africa PEST Analysis
Figure 7. Antacid Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Antacid Market - Revenue Forecasts and Analysis - 2019- 2027
Figure 9. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 10. Tablet: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Liquid: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 14. Proton Pump Inhibitors: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. H? Antagonist: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Acid Neutralizers: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Magaldrate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Sucralfate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 21. Hospital Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Retail Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Online Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Middle East & Africa: Antacid Market, by Key Country - Revenue (2019) (USD Million)
Figure 25. Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
Figure 26. Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 27. UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 28. South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 29. Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 31. Growth Strategies Done by the Companies in the Market, (%)

Table 1. Saudi Arabia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 2. Saudi Arabia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 3. Saudi Arabia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. UAE: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 6. UAE: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 7. UAE: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 8. UAE: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. South Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 12. South Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Rest of Middle East and Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 14. Rest of Middle East and Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 15. Rest of Middle East and Africa Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Middle East and Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Antacid Market

The List of Companies - Middle East and Africa Antacids Market

? Bayer AG
? GlaxoSmithKline plc
? Takeda Pharmaceutical Company Limited
? Sun Pharmaceutical Industries Ltd
? Sanofi
? Boehringer Ingelheim International GmbH
? Dr. Reddy's Laboratories
? Pfizer Inc
? Reckitt Benckiser Group Plc
? Procter & Gamble